Online course to help adults manage parasomnias
Official title: Development and Online Evaluation of an Online Course for Parasomnias
Run by University of Manitoba · NCT07361315 · Data updated 2026-11-12
This trial tests whether a four-week online course can help adults with parasomnias reduce how often episodes happen and how distressed they feel.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | University of Manitoba Academic / other |
| Locations | 1 site (Winnipeg, Manitoba) |
| Status | Recruiting |
| Started | November 14, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | January 23, 2026 |
| Trial ID | NCT07361315 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults (≥18) referred for a parasomnia who meet diagnostic criteria, have symptoms for at least six months, can read English, have device/internet access, and do not have excluded medications or untreated major sleep or neurological disorders.
✕Probably not a fit
People using excluded psychiatric or sedative medications, those with seizures or untreated sleep apnea/narcolepsy/restless legs, children, or those without internet access are unlikely to benefit from this specific intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-blind randomized controlled trial compares a four-week online parasomnia education course to a sleep hygiene education control in 20 adult outpatients referred to a behavioral sleep medicine clinic. Participants complete pre- and post-treatment surveys and sleep diaries to measure changes in parasomnia frequency and distress as primary outcomes. Secondary outcomes include work and social adjustment, mood, anxiety, stress, fatigue, sleepiness, insomnia, and perceived cognitive interference. Recruitment is from the clinic waiting list, with eligibility confirmed by clinical interview and screening for exclusionary medications and untreated sleep disorders.
Why it matters
Potential benefit: If successful, the course could reduce parasomnia episodes and related distress while improving sleep-related functioning and mood for participants.
How similar studies have gone: Behavioral therapies and education have shown benefits for some parasomnias, but delivering an evidence-based parasomnia course online is relatively novel and not yet well established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * physician referred for parasomnia * meet criteria for parasomnia on the Structured Clinical Interview for Sleep Disorders (SCISD-R) * age \>= 18 years * parasomnia duration \>= 6 months * English reading, sighted * access to device. Exclusion Criteria: * currently taking one of Lithium, Thioridazine, Chlorpromazine, Perphenazine, Methaqualone, Amitriptyline, Selective Serotonin Re-Uptake Inhibitors, Serotonin and Norepinephrine Re-Uptake inhibitors, or Zopiclone * seizure or major neurological disorder * untreated sleep apnea, restless legs syndrome, or narcolepsy
Where it's running
-
Psychealth Center, University of Manitoba
Winnipeg, Manitoba, Canada Recruiting
Study contacts
- Principal investigator: Norah Vincent, PhD — University of Manitoba
- Study coordinator: Cassidy Santos Research Coordinator, B.A.
- Email: csantos17@hsc.mb.ca
- Phone: 1-204--891-6235
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
-
Swedish BioFINDER Sleep program for early Parkinson's disease and REM sleep behavior disorder
This project will test whether sleep studies, brain and heart imaging, and fluid biomarkers can identify synuclein pathology and help predict progression in people with early Parkinson's disease or idiopathic REM sleep behavior disorder.
-
Ultra-high-resolution PET imaging of aging, neurodegeneration, and psychotic disorders
We will test whether ultra-high-resolution PET and 3T MRI scans can reveal early brain and spinal cord changes in healthy adults and people with Alzheimer's, Parkinson's disease, ALS, PSP, REM sleep behavior disorder, or psychotic disorders.
-
Pain testing for people with idiopathic REM sleep behavior disorder
This study will test whether people with idiopathic REM sleep behavior disorder feel and report pain differently using brief thermal pain tests and questionnaires.
-
Gentle nighttime sounds to boost deep sleep and slow brain changes in iRBD and early Parkinson's
This test will see if playing gentle sounds during sleep can boost deep slow-wave sleep and slow brain changes in people with isolated REM sleep behavior disorder or early Parkinson's disease.
-
Examining sleep disorders in Parkinson's disease and related conditions
This study is testing how sleep problems affect people with Parkinson's disease and REM sleep behavior disorder to better understand their sleep patterns.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.